McClellan MB - Search Results

1

Fisher ES, McClellan MB, Safran DG. Fisher ES, et al. Among authors: mcclellan mb. N Engl J Med. 2011 Dec 29;365(26):2445-7. doi: 10.1056/NEJMp1112442. N Engl J Med. 2011. PMID: 22204720 No abstract available.

2

Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries.

Weiss JP, Saynina O, McDonald KM, McClellan MB, Hlatky MA. Weiss JP, et al. Among authors: mcclellan mb. Am J Med. 2002 May;112(7):519-27. doi: 10.1016/s0002-9343(02)01078-1. Am J Med. 2002. PMID: 12015242

3

Solutions for filling gaps in accountable care measure sets.

Valuck T, Dugan D, Dubois RW, Westrich K, Penso J, McClellan M. Valuck T, et al. Am J Manag Care. 2015 Oct;21(10):723-8. Am J Manag Care. 2015. PMID: 26633096

4

The FDA Sentinel Initiative - An Evolving National Resource.

Platt R, Brown JS, Robb M, McClellan M, Ball R, Nguyen MD, Sherman RE. Platt R, et al. N Engl J Med. 2018 Nov 29;379(22):2091-2093. doi: 10.1056/NEJMp1809643. N Engl J Med. 2018. PMID: 30485777 No abstract available.

5

Improving Oncology Quality Measurement in Accountable Care: Filling Gaps with Cross-Cutting Measures.

Valuck T, Blaisdell D, Dugan DP, Westrich K, Dubois RW, Miller RS, McClellan M. Valuck T, et al. J Manag Care Spec Pharm. 2017 Feb;23(2):174-181. doi: 10.18553/jmcp.2017.23.2.174. J Manag Care Spec Pharm. 2017. PMID: 28125364

6

Improving Care And Lowering Costs: Evidence And Lessons From A Global Analysis Of Accountable Care Reforms.

McClellan M, Udayakumar K, Thoumi A, Gonzalez-Smith J, Kadakia K, Kurek N, Abdulmalik M, Darzi AW. McClellan M, et al. Health Aff (Millwood). 2017 Nov;36(11):1920-1927. doi: 10.1377/hlthaff.2017.0535. Health Aff (Millwood). 2017. PMID: 29137499

7

Accountable care around the world: a framework to guide reform strategies.

McClellan M, Kent J, Beales SJ, Cohen SI, Macdonnell M, Thoumi A, Abdulmalik M, Darzi A. McClellan M, et al. Health Aff (Millwood). 2014 Sep;33(9):1507-15. doi: 10.1377/hlthaff.2014.0373. Health Aff (Millwood). 2014. PMID: 25201654

8

New FDA breakthrough-drug category--implications for patients.

McClellan M, Sigal E. McClellan M, et al. N Engl J Med. 2014 Jul 3;371(1):87-8. doi: 10.1056/NEJMc1405337. N Engl J Med. 2014. PMID: 24988577 No abstract available.

9

Drug safety reform at the FDA--pendulum swing or systematic improvement?

McClellan M. McClellan M. N Engl J Med. 2007 Apr 26;356(17):1700-2. doi: 10.1056/NEJMp078057. Epub 2007 Apr 13. N Engl J Med. 2007. PMID: 17435081 No abstract available.

10

The first months of the prescription-drug benefit--a CMS update.

Bach PB, McClellan MB. Bach PB, et al. Among authors: mcclellan mb. N Engl J Med. 2006 Jun 1;354(22):2312-4. doi: 10.1056/NEJMp068108. N Engl J Med. 2006. PMID: 16738266 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results